FerlayJ,BrayF,PisaniP,ParkinDM. GLOBOCAN, 2004.Cancer incidence, mortality, and prevalence worldwide,IACR Cancer Base, No.5, Version 2 -
EzzeldinM,AhmedA,TawfikR,AboelkhairM,Bakr M. Past, 2008.present and future of colorectal cancer in Kingdom of Saudi Arabia,Saudi J Gastroentrol 14 178 -82
CarolyC,PeterF,LawrenceJ,HarryS,StanleyR, 2000.Prognostic factors in colorectal cancer, College of American Pathologist Consensus Statement 1999,Arch Pathol Lab Med 124 -
MayerA,TakimotoM., 1993.The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer,Cancer 71 2454 -60
SpanoJ,FagradR,SoriaJ,RixeO,KhayatD., 2005.Epidermal growth factor receptor signaling in colorectal cancer: preclinical data and therapeutic perspectives,Ann Oncol 16 189 -94
DebucquoyI,MachielsJ,McBrideW,HaustermansK., 2010.Integration of epidermal growth factor receptor inhibitors with preoperative chemoradiation,Clin Cancer Res 15 2709 -14
DeschoolmeesterV,BayM,SpecenierP,LardonF,VermorkenJB, 2010.A Review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy,Oncologist 15 699 -731
SteeleRJ,KellyP,EllulB, 1990.Immunohistochemical detection of epidermal growth factor receptors on human colonic carcinomas,Br J Cancer 61 325 -6
SaltzLB,MeropolNJ,LoehrerPJ, 2004.Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor,J Clin Oncol 22 1201 -8
Al-AhwalMS,AL-GhamdiAA, 2005.Pattern of colorectal cancer at two hospitals in the western region of Saudi Arabia,Saudi J Gastroenterol 11 164 -9
StephenB,CarolynC, 2010.The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM,Ann Surg Oncol 17 1471 -4
GoldsteinNS,ArminM., 2001.Epidermal growth factor receptor immunohistochemical reactivity in patients with American Joint Committee on Cancer stage IV colon adenocarcinoma,Cancer 92 1331 -46
SpanoJP,LagorceC,AtlanD,MilanoG,DomontJ, 2005.Impact of EGFR expression on colorectal cancer patient prognosis and survival,Ann Oncol 16 102 -8
2004.National cancer registry, ministry of health,Kingdom of Saudi Arabia 1999 -2000
LaohavinijS,ManeechavakajornJ,TechatanolP, 2010.Prognostic factors for survival in colorectal cancer patients,J Med Assoc Thai 93 1156 -66
PatelDK., 2008.Clinical use of anti-epidermal growth factor receptor monoclonal antibodies in metastatic colorectal cancer,Pharmacotherapy 28 31S -41S
LockhartAC, 2005.The epidermal growth factor receptor as a target for colorectal cancer therapy,Semin Oncol 32 52 -60
LetoSM,TrusolinoL, 2014.Primary and acquired resistance to EGFR-targeted therapies in colorectal cancer: impact on future treatment strategies,J Mol Med 92 709 -22
OkadaY,MiyamotoH,GojiT,TakayamaT, 2014.Biomarkers for predicting the efficacy of anti-epidermal growth factor receptor antibody in the treatment of colorectal cancer,Digestion 89 18 -23
LyallMS,DundasSR,CurranS,MurrayGI, 2006.Profilling markers of prognosis in colorectal cancer,Clin Cancer Res 12 1184 -91
GaliziaG,LietoE,FeraraccioF,DeitaF, 2006.Prognostic significance of epidermal growth factor receptor expression in colon cancer patients undergoing curative surgery,Ann Surg Oncol 13 823 -35